Janssen Announces Significant Data from Two SC Sirukumab Phase 3s as RA Treatment
Go back to Janssen Announces Significant Data from Two SC Sirukumab Phase 3s as RA Treatment| AbbVie (NYSE: ABBV) | Delayed: 166.75 -1.05 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $167.80 | 52 Week High | $68.12 | |||
| Open | $167.66 | 52 Week Low | $50.71 | |||
| Day High | $169.29 | P/E | 36.17 | |||
| Day Low | $165.57 | EPS | $4.61 | |||
| Volume | 3,618,792 | |||||
| Johnson & Johnson (NYSE: JNJ) | Delayed: 147.05 -1.48 (1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.53 | 52 Week High | $126.07 | |||
| Open | $149.37 | 52 Week Low | $94.28 | |||
| Day High | $149.58 | P/E | 30.57 | |||
| Day Low | $146.33 | EPS | $4.81 | |||
| Volume | 5,132,936 | |||||
